Showing 161 - 180 results of 14,990 for search '(( ct cases increased ) OR ((( a greatest decrease ) OR ( ((b large) OR (a large)) decrease ))))', query time: 0.57s Refine Results
  1. 161
  2. 162
  3. 163
  4. 164
  5. 165

    Supplementary Material for: Dysregulated MDR1 by PRDM1/Blimp1 Is Involved in the Doxorubicin Resistance of Non-Germinal Center B-Cell-Like Diffuse Large B-Cell Lymphoma by Qing K. (11765465)

    Published 2021
    “…<b><i>Introduction:</i></b> The chemoresistance mechanism of diffuse large B-cell lymphoma (DLBCL) is still poorly understood, and patient prognosis remains unsatisfactory. …”
  6. 166
  7. 167
  8. 168

    DWV abundance variable over time and greatest in October. by Cayley Faurot-Daniels (9354170)

    Published 2020
    “…<p>A. DWV abundance varied over time and was greatest at the end of the study (day of study<sub>edf</sub> = 4.253, p-value = 0.0001). …”
  9. 169
  10. 170
  11. 171
  12. 172
  13. 173

    Table 2_Hyper-fractionated radiotherapy as a bridging strategy to enhance CAR-T efficacy by regulating T-cell co-stimulatory molecules in relapsed/refractory diffuse large B-cell l... by Jing Ruan (5117951)

    Published 2024
    “…After hyper-fractionated radiotherapy, peripheral PD1+CD8+T/T ratio significantly decreased while quantitative serum proteomics profiling showed a decrease in sCD28.…”
  14. 174

    Table 1_Hyper-fractionated radiotherapy as a bridging strategy to enhance CAR-T efficacy by regulating T-cell co-stimulatory molecules in relapsed/refractory diffuse large B-cell l... by Jing Ruan (5117951)

    Published 2024
    “…After hyper-fractionated radiotherapy, peripheral PD1+CD8+T/T ratio significantly decreased while quantitative serum proteomics profiling showed a decrease in sCD28.…”
  15. 175

    Table 3_Hyper-fractionated radiotherapy as a bridging strategy to enhance CAR-T efficacy by regulating T-cell co-stimulatory molecules in relapsed/refractory diffuse large B-cell l... by Jing Ruan (5117951)

    Published 2024
    “…After hyper-fractionated radiotherapy, peripheral PD1+CD8+T/T ratio significantly decreased while quantitative serum proteomics profiling showed a decrease in sCD28.…”
  16. 176
  17. 177
  18. 178
  19. 179
  20. 180